Table 3.
Summary of the results (N=112 studies; N (%))
| Dimensions | Not reported | N* | + | − | +/− | Ø |
|---|---|---|---|---|---|---|
| Outcomes | ||||||
| Clinical processes | 47 | 65 (100) | 61 (94) | 3 (5) | 0 (0) | 1 (1) |
| Patients’ health outcomes | 87 | 25 (100) | 24 (96) | 1 (4) | 0 (0) | 0 (0) |
| Productivity, efficiency, costs | 96 | 16 (100) | 14 (88) | 1 (6) | 0 (0) | 1 (6) |
| Clinicians’ satisfaction | 99 | 13 (100) | 11 (85) | 2 (15) | 0 (0) | 0 (0) |
| Patients’ satisfaction | 79 | 33 (100) | 27 (82) | 5 (15) | 0 (0) | 1 (3) |
| Patients’ empowerment | 97 | 15 (100) | 12 (80) | 1 (7) | 0 (0) | 2 (13) |
| Technology | ||||||
| Compatibility | 70 | 42 (100) | 26 (62) | 14 (33) | 2 (5) | 0 (0) |
| Simplicity | 72 | 40 (100) | 22 (55) | 10 (25) | 8 (20) | 0 (0) |
| Implementation | ||||||
| Trialability | 90 | 22 (100) | 17 (77) | 3 (14) | 2 (9) | 0 (0) |
| Observability | 107 | 5 (100) | 3 (60) | 2 (40) | 0 (0) | 0 (0) |
N*, Number of studies for which the dimension was evaluated; +, positive evaluation; −, negative evaluation; +/−, evaluation that was both positive and negative; Ø, no influence.